menu search

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...

November 3, 2023, 7:41 pm

Brainstorm cell therapeutics: i anticipate a positive adcom but there are major risks

BCLI has completed a phase 3 trial in ALS. Despite not meeting the primary endpoint BCLI is still applying for approval and an AdCom meeting is schedu...

September 15, 2023, 6:03 pm

Investors may not have seen the best from eli lilly stock yet. here's why.

Eli Lilly's type 2 diabetes treatment, called Mounjaro, is helping fuel new growth for the company. In addition to diabetes, Eli Lilly is looking to <...

September 10, 2023, 6:12 am

Uber is on a fast track after delivering its first profits

Uber stock has surged 85.6% on the year entering trading on Thursday as it has reached profitability. The company is IBD's Stock of The Day....

September 7, 2023, 2:26 pm

Nai ohio equities starts training program, aims to grow firm

The NAI Ohio Equities fast track training program will start next week, with program participants meeti...

August 31, 2023, 12:59 am

Inhibrx: inbrx-101 developments constructive, market-generated data not so much

INBX is researching a breakthrough for Alpha-1 Antitrypsin deficiency and has received regulatory support for its INBRX-101 pipeline. The AATD treatme...

August 17, 2023, 4:41 pm

Point biopharma: stock has upcoming catalysts with 2 therapies in phase 3 trials

POINT Biopharma has two therapies in Phase 3 development with fast track designation, which creates the...

August 1, 2023, 12:23 am

Fda grants fast track designation to ivs-3001, a car-t cell therapy in the treatment of renal cell carcinoma

Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) — Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies fo...

July 31, 2023, 10:00 am

Astria (atxs) rises 5% on fast track tag for angioedema drug

Astria (ATXS) gets FDA's fast track tag for its lead product candidate, STAR-0215, which is currently b...

July 21, 2023, 9:12 am

Fda grants fast track designation for ambrx’s arx517 for the treatment of metastatic castration-resistant prostate cancer

SAN DIEGO, July 19, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that the U.S. Food an...

July 19, 2023, 1:03 pm

Valneva: vla1553 takes the lead in the chikungunya vaccine race

Positive Phase 3 data from Bavarian Nordic's chikungunya virus (CHIKV) vaccine candidate, PXVX0317, reinforces bullish view on Valneva's VLA1553 due t...

July 18, 2023, 4:17 am

Genprex shares rise as fda grants third fast track designation for small cell lung cancer therapeutic reqorsa

Genprex, Inc. (NASDAQ:GNPX) shares moved higher in pre-market trading after the clinical-stage gene therapy company announced that the US Food and Dru...

June 28, 2023, 9:31 am

Tesla charging technology put on fast track to become us industry standard

Tesla's electric-vehicle charging technology is being put on a fast track to become a U.S. standard, th...

June 27, 2023, 12:09 pm

Innate (ipha) gains as blood cancer drug gets fast track tag

Innate (IPHA) and Sanofi's SAR'579 / IPH6101 get fast track Designation in the United States for the tr...

June 9, 2023, 11:42 am

Rocket (rckt) heart disease drug gets fast track & orphan drug tag

The FDA grants fast track tag and orphan drug designation to Rocket's (RCKT) investigational gene thera...

June 9, 2023, 10:27 am

Why shares of innate pharma jumped thursday

A therapy Innate Pharma and Sanofi are developing was granted fast track Designation by the FDA. Innate...

June 8, 2023, 1:06 pm

Bristol myers (bmy) thrombosis drug gets fast track designation

Bristol Myers (BMY) obtains fast track Designation from the FDA for milvexian, which is being developed...

May 26, 2023, 1:35 pm

Bayer's (bayry) arrhythmia prevention drug gets fast track tag

Bayer's (BAYRY) oral FXIa inhibitor, asundexian, gets the FDA's fast track Designation, as a preventive...

May 17, 2023, 12:47 pm

Tenaya therapeutics reports first quarter 2023 financial results and provides business update

TN-201 Received fast track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301...

May 10, 2023, 8:19 pm

Lantheus and point biopharma announce fda grants fast track designation for ¹⁷⁷lu-pnt2002 for the treatment of metastatic castration resistant prostate cancer

BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to i...

April 24, 2023, 11:30 am


Search within

Pages Search Results: